The American Society for Gastrointestinal Endoscopy recently released new clinical guidance on the screening for pancreatic cancer in people with genetic susceptibility (Gastrointest Endosc 2022 Feb 16. doi:10.1016/j.gie.2021.12.001). GEN’s Sarah Tilyou spoke with lead author Mandeep S. Sawhney, MD, MS, FASGE, a gastroenterologist at Beth Israel Deaconess Medical Center and an associate professor of medicine at Harvard Medical School, in Boston, about the impetus for the guidelines and what they mean to GI practice.
Trending
- AI Companion Tool Identifies Food Triggers Based on IBS Sensitivity Testing (CLP)
- British startup BoobyBiome raises €2.8 million for infant health with breast milk microbiome breakthrough (EU-Startups)
- Locum tenens: Reclaiming purpose, autonomy, and financial freedom in medicine (KevinMD)
- Getting Ahead of Gastrointestinal Cancer (Medscape)
- Can AI and Molecular Testing Outperform Colonoscopy? (The Pathologist)
- Precision Gastroenterology: Harnessing Personalized Medicine for Transformative Patient Care (ASGE)
- Transforming Colonoscopy: The Role of Mechanical Enhancements in Boosting Polyp Detection Rates (ReachMD)
- Health Insurance Premiums To Rise Well Above Inflation For Most Americans (Forbes)